Inovio Pharmaceuticals

INONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$128.213 M

$1.24 +0.00%

Close of 21 Sept 2026

Revenue

$65.3K

#3601 by revenue

Earnings

-$85.0M

Loss-making

Shares outstanding

103,397,518

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#290TuHURA BiosciencesHURA$138.9M
#291Unicycive TherapeuticsUNCY$132.9M
#292Inovio PharmaceuticalsINO$128.2M
#293Biomea FusionBMEA$123.9M
#294OnKure TherapeuticsOKUR$123.9M

What if Inovio Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$292,792.85

Per share 236,123× higher

Bitcoin $1.72T

$16,632.93

Per share 13,414× higher

Nvidia $5.48T

$52,997.96

Per share 42,740× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Inovio Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.